Amylyx Pharmaceuticals, Inc. (AMLX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.53
Day's range
$14.57

Amylyx Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 16.63 M $231.16 M   0.68% 17.59%
BLACKROCK, INC. 05/13/2026 8.83 M $122.72 M   -2.49% 9.34%
PERCEPTIVE ADVISORS LLC 05/29/2026 8.28 M $115.16 M   0.00% 8.76%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 6.24 M $86.79 M   0.00% 6.60%
COMMODORE CAPITAL LP 05/15/2026 5.65 M $78.54 M   0.00% 5.97%
JANUS HENDERSON GROUP PLC 05/18/2026 4.99 M $69.26 M   11.65% 5.27%
SATURN V CAPITAL MANAGEMENT LLC 05/15/2026 4.35 M $60.46 M   -3.26% 4.60%
05/15/2026 4.14 M $57.57 M   100.00% 4.38%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 3.56 M $49.49 M   28.22% 3.77%
FIRST LIGHT ASSET MANAGEMENT, LLC 05/15/2026 3.19 M $44.35 M   -4.91% 3.37%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 2.99 M $41.52 M   -3.93% 3.16%
GOLDMAN SACHS GROUP INC 05/15/2026 2.63 M $36.50 M   0.49% 2.78%
STATE STREET CORP 05/15/2026 2.36 M $32.85 M   14.17% 2.50%
FRANKLIN RESOURCES INC 05/13/2026 2.26 M $31.44 M   88.45% 2.39%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.21 M $30.74 M   2.10% 2.34%
MORGAN STANLEY 05/15/2026 2.18 M $30.24 M   -7.81% 2.30%
ALMITAS CAPITAL LLC 05/15/2026 2.12 M $29.50 M   0.00% 2.24%
GREAT POINT PARTNERS LLC 05/15/2026 1.75 M $24.33 M   0.00% 1.85%
05/14/2026 1.60 M $22.22 M   100.00% 1.69%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 1.53 M $21.27 M   -7.27% 1.62%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 1.51 M $21.04 M   0.05% 1.60%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.33 M $18.50 M   -0.40% 1.41%
DEUTSCHE BANK AG\ 05/06/2026 1.27 M $17.62 M   -4.91% 1.34%
SIREN, L.L.C. 05/14/2026 1.23 M $17.10 M   100.00% 1.30%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.11 M $15.39 M   28.95% 1.17%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 1.00 M $13.91 M   12.38% 1.06%
BARCLAYS PLC 05/15/2026 971.85 K $13.51 M   229.24% 1.03%
05/08/2026 944.78 K $13.13 M   100.00% 1.00%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 903.19 K $12.54 M   17.11% 0.96%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 868.33 K $12.07 M   -13.52% 0.92%
WOODLINE PARTNERS LP 05/15/2026 845.80 K $11.76 M   0.05% 0.89%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 800.00 K $11.12 M   0.00% 0.85%
NORTHERN TRUST CORP 05/14/2026 779.91 K $10.84 M   -16.83% 0.82%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 716.23 K $9.96 M   0.45% 0.76%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 702.24 K $9.76 M   70.09% 0.74%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 700.00 K $9.73 M   -26.32% 0.74%
STEMPOINT CAPITAL LP 05/18/2026 669.69 K $9.31 M   18.50% 0.71%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 621.46 K $8.64 M   62.79% 0.66%
JUPITER ASSET MANAGEMENT LTD 05/12/2026 592.65 K $8.24 M   3,705.41% 0.63%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 586.15 K $8.15 M   100.00% 0.62%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 535.68 K $7.45 M   -35.90% 0.57%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 499.76 K $6.95 M   0.00% 0.53%
CITADEL ADVISORS LLC 05/15/2026 411.53 K $5.72 M   19.30% 0.44%
FEDERATED HERMES, INC. 05/11/2026 363.55 K $5.05 M   -20.52% 0.38%
HIGHVISTA STRATEGIES LLC 05/15/2026 352.09 K $4.89 M   47.43% 0.37%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 350.00 K $4.87 M   -12.50% 0.37%
UBS GROUP AG 05/05/2026 324.32 K $4.51 M   -40.31% 0.34%
TFG ASSET MANAGEMENT GP LTD 05/15/2026 317.88 K $4.42 M   16.51% 0.34%
IA GLOBAL ASSET MANAGEMENT INC. 04/23/2026 304.79 K $4.24 M   100.00% 0.32%
NUVEEN, LLC 04/30/2026 264.90 K $3.68 M   -6.71% 0.28%

Amylyx Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 218 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals Inc. The most heavily invested institutionals were:

FMR LLC: 16.63 M

BlackRock, Inc.: 8.83 M

PERCEPTIVE ADVISORS LLC: 8.28 M

TCG Crossover Management, LLC: 6.24 M

COMMODORE CAPITAL LP: 5.65 M

JANUS HENDERSON GROUP PLC: 4.99 M

120.71% of Amylyx Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 117.67 M shares in the last 24 months. This purchase volume represents approximately $1.68 B in transactions.